(Total Views: 579)
Posted On: 08/25/2025 9:17:07 AM
Post# of 158138
Funding needs:
Based on FDA submission to accept our 42 patient data, our CRC/Alzheimer’s trials status, PD-L1 observation of 9 tumor types including g Compassionate Use....
I will guess $20 - $30m initial raise to go with remaining $9m.
Per Dr. J, we only need to verify:
(1) LL upregulating PD-L1. Made video comment of LL has upregulated 90% of patients.
(2) LL/ICI combo once again ='s survival benefit.
No need for tons of cash right now or especially any low-ball pharma deal.
The historical deals, yes...plural, come right after we see:
"Game Changer" !!!
Based on FDA submission to accept our 42 patient data, our CRC/Alzheimer’s trials status, PD-L1 observation of 9 tumor types including g Compassionate Use....
I will guess $20 - $30m initial raise to go with remaining $9m.
Per Dr. J, we only need to verify:
(1) LL upregulating PD-L1. Made video comment of LL has upregulated 90% of patients.
(2) LL/ICI combo once again ='s survival benefit.
No need for tons of cash right now or especially any low-ball pharma deal.
The historical deals, yes...plural, come right after we see:
"Game Changer" !!!
(8)
(0)
